Taysha Gene Therapies
TSHA
#5787
Rank
โ‚ฌ1.12 B
Marketcap
3,44ย โ‚ฌ
Share price
-5.51%
Change (1 day)
-1.04%
Change (1 year)

Taysha Gene Therapies (TSHA) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚ฌ75.85 Million

According to Taysha Gene Therapies's latest financial reports the company's total liabilities are โ‚ฌ75.85 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Taysha Gene Therapies - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ0.11 B11.59%
2021-12-31โ‚ฌ0.10 B1599.17%
2020-12-31โ‚ฌ6.16 M4501.78%
2019-12-31โ‚ฌ0.13 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚ฌ21.36 M-71.83%๐Ÿ‡บ๐Ÿ‡ธ USA